The Open Issues Regarding Cyclin-Dependent Kinase 4/6 Inhibitors in the Management of Advanced Breast Cancer

Eitemau Tebyg

• Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer
  gan: Husinka, Lakyn, et al.
  Cyhoeddwyd: (2020)
• Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2− Advanced Breast Cancer
  gan: Xie, Ning, et al.
  Cyhoeddwyd: (2020)
• Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 Inhibitors
  gan: Ettl, Johannes
  Cyhoeddwyd: (2019)
• Cyclin‐dependent kinase (CDK) inhibitors for hormone receptor‐positive advanced breast cancer
  gan: Syn, Nicholas LX, et al.
  Cyhoeddwyd: (2018)
• Are Cyclin‐Dependent Kinase 4/6 Inhibitors Without Future in Neuroendocrine Tumors?
  gan: Pusceddu, Sara, et al.
  Cyhoeddwyd: (2020)